In lung adenocarcinoma tumors from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga, accessed on 19 January 2020), we only observed a slight downregulation of CD209 (β=−0.26, p=0.07) compared to normal tissues. This evidence concerns the gene CD209 and lung adenocarcinoma.